Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan;26(1):20-26.
doi: 10.1016/j.cjtee.2022.06.008. Epub 2022 Jul 3.

Pharmacological properties and mechanisms of Notoginsenoside R1 in ischemia-reperfusion injury

Ting Zhu  1 , Qi Wan  2
Affiliations
Review

Pharmacological properties and mechanisms of Notoginsenoside R1 in ischemia-reperfusion injury

Ting Zhu et al. Chin J Traumatol. 2023 Jan.

Abstract

Panax notoginseng is an ancient Chinese medicinal plant that has great clinical value in regulating cardiovascular disease in China. As a single component of panax notoginosides, notoginsenoside R1 (NGR1) belongs to the panaxatriol group. Many reports have demonstrated that NGR1 exerts multiple pharmacological effects in ischemic stroke, myocardial infarction, acute renal injury, and intestinal injury. Here, we outline the available reports on the pharmacological effects of NGR1 in ischemia-reperfusion (I/R) injury. We also discuss the chemistry, composition and molecular mechanism underlying the anti-I/R injury effects of NGR1. NGR1 had significant effects on reducing cerebral infarct size and neurological deficits in cerebral I/R injury, ameliorating the impaired mitochondrial morphology in myocardial I/R injury, decreasing kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in renal I/R injury and attenuating jejunal mucosal epithelium injury in intestinal I/R injury. The various organ anti-I/R injury effects of NGR1 are mainly through the suppression of oxidative stress, apoptosis, inflammation, endoplasmic reticulum stress and promotion of angiogenesis and neurogenesis. These findings provide a reference basis for future research of NGR1 on I/R injury.

Keywords: Chemistry; Ischemia/reperfusion injury; Molecular mechanism; Notoginsenoside R1; Pharmacological properties.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Chemical structure of NGR1 and related ginsenosides.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zhang W., Song J.K., Du G.H., et al. Apoptosis signal transduction pathways in ischemia-reperfusion injury. Chin Pharmaceut J. 2015;50:565–569. https://10.11669/cpj.2015.07.001 - DOI
    1. Han J.Y., Li Q., Ma Z.Z., et al. Effects and mechanisms of compound Chinese medicine and major ingredients on microcirculatory dysfunction and organ injury induced by ischemia/reperfusion. Pharmacol Ther. 2017;177:146–173. https://10.1016/j.pharmthera.2017.03.005 - DOI - PubMed
    1. Lee K.Y., Heo J.H., Lee S.I., et al. Rescue treatment with abciximab in acute ischemic stroke. Neurology. 2001;56:1585–1587. https://10.1212/wnl.56.11.1585 - DOI - PubMed
    1. Moskowitz M.A., Lo E.H., Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67:181–198. https://10.1016/j.neuron.2010.07.002 - DOI - PMC - PubMed
    1. Chavez J.C., Hurko O., Barone F.C., et al. Pharmacologic interventions for stroke: looking beyond the thrombolysis time window into the penumbra with biomarkers, not a stopwatch. Stroke. 2009;40:e558–563. https://10.1161/strokeaha.109.559914 - DOI - PubMed

Substances